A carregar...
Developing new pharmacotherapeutic approaches to treating sickle-cell disease
Survival for patients with SCD has been prolonged by improvements in supportive care, including vaccinations, antibiotic prophylaxis, and overall medical management, including tra nsfusion. However, there remains only one approved, partially effective drug for sickle cell disease—hydroxyurea (hydrox...
Na minha lista:
| Publicado no: | ISBT Sci Ser |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5418585/ https://ncbi.nlm.nih.gov/pubmed/28484512 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/voxs.12305 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|